Irritable bowel syndrome (IBS) is a chronic functional gastrointestinal disease that affects roughly 15% of people in America. A functional gastrointestinal disease is described as one where the GI tract does not always operate normally, but there aren’t any discernible structural abnormalities. Likewise, when physicians administer some tests, the results normally return as normal.
In 2019, “The American Journal of Gastroenterology” explained a study where researchers found differences between the bowel bacteria of individuals who have irritable bowel syndrome and people who have healthy digestive tracts. Some genera of bacteria are more prevalent in patients with IBS, and many others are somewhat less common. The scientists theorized that differences in gut bacteria inhabitants could influence a patient’s ability to digest certain foods.
OPEN NEXT PAGE TO SEE MORE
